Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
149.22
+1.18 (0.80%)
At close: Dec 5, 2025, 4:00 PM EST
150.80
+1.58 (1.06%)
After-hours: Dec 5, 2025, 6:19 PM EST
Axsome Therapeutics Stock Forecast
Stock Price Forecast
According to 20 professional analysts, the 12-month price target for Axsome Therapeutics stock ranges from a low of $143 to a high of $205. The average analyst price target of $176 forecasts a 17.95% increase in the stock price over the next year.
Price Target: $176.00 (+17.95%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 6, 2025.
Analyst Ratings
The average analyst rating for Axsome Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 8 | 9 |
| Buy | 9 | 10 | 10 | 11 | 11 | 11 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 17 | 18 | 19 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $200 → $202 | Buy | Maintains | $200 → $202 | +35.37% | Nov 6, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $194 → $196 | Buy | Maintains | $194 → $196 | +31.35% | Nov 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $180 → $185 | Strong Buy | Maintains | $180 → $185 | +23.98% | Nov 4, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $189 → $198 | Buy | Maintains | $189 → $198 | +32.69% | Nov 4, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $163 → $157 | Buy | Maintains | $163 → $157 | +5.21% | Nov 4, 2025 |
Financial Forecast
Revenue This Year
641.02M
from 385.69M
Increased by 66.20%
Revenue Next Year
1.01B
from 641.02M
Increased by 57.56%
EPS This Year
-3.74
from -5.99
EPS Next Year
0.93
from -3.74
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 669.6M | 1.2B | ||||
| Avg | 641.0M | 1.0B | ||||
| Low | 600.7M | 880.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 73.6% | 80.3% | ||||
| Avg | 66.2% | 57.6% | ||||
| Low | 55.8% | 37.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.18 | 3.18 | ||||
| Avg | -3.74 | 0.93 | ||||
| Low | -4.02 | -1.88 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.